Actively Recruiting
Useability and Acceptability of the CUE1 Device in Older People With Parkinson's Disease
Led by Dr Alistair Mackett · Updated on 2024-05-28
20
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The CUE1 device is a non-invasive wearable device for people with Parkinson's Disease (PD) approved for sale in the UK. The CUE1 device utilises two established methods to improve motor symptoms in PD, namely pulsed cueing and vibrotactile stimulation. Many people with PD wish to explore non-pharmacological interventions as an adjunct to manage their motor symptom. Study design and eligibility: This feasibility study is to establish whether the CUE1 device is a useable and acceptable device for older people with PD. 20-25 participants aged \>60 years with PD will be recruited from a movement disorder service to the study. Methodology: Participants will undertake baseline assessments of motor symptoms and quality of life with a PD nurse assessor in their own home. Following this the CUE1 device will be fitted and repeat assessments of motor symptoms will take place after 20 minutes. The participants will complete a daily diary of useability and acceptability for 4 weeks. A second visit will occur at 4 weeks with the same PD nurse assessor where the final set of motor symptom and quality of life assessments will be completed.
CONDITIONS
Official Title
Useability and Acceptability of the CUE1 Device in Older People With Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals under the care of a Cambridge University Hospitals Foundation Trust movement disorder service with an established clinical diagnosis of Parkinson's disease based on the UK Brain bank criteria
- Age between 60 and 100 years
You will not qualify if you...
- Co-existing significant neurological disorders such as disabling stroke, multiple sclerosis, dementia, or motor neurone disease
- Diagnosis of atypical parkinsonian disorders like multiple systems atrophy, progressive supranuclear palsy, or cortical basal degeneration syndrome
- Physical impairments causing significant mobility issues, including severe lower limb osteoarthritis
- Trauma or pain to the sternum
- Use of other medical devices such as pacemakers, deep brain stimulators, or TENS machines
- Lack of capacity to consent to the study
- Sensitivity to medical adhesives
- Current participation in another intervention research trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cambridge University Hospitals Foundation Trust
Cambridge, United Kingdom
Actively Recruiting
Research Team
A
Alistair J Mackett, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here